Euploid Pharmaceuticals Private Limited

This company manufactures and provides a wide range of pharmaceutical products, including anti-diabetics, antibiotics, vitamins, and more.

2015 | Bangaluru, Karnataka (India) | Active
Last Updated:

Euploid Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 9 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 15.18 Cr
  • Revenue Growth 3.58%
  • Profit Growth -283.91%
  • Ebitda 17.91%
  • Net Worth 693.18%
  • Total Assets 197.68%

About Euploid Pharmaceuticals

Euploid Pharmaceuticals Private Limited (EPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 August 2015 (Nine years and nine months 9 days old ). Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.

The company currently has active open charges totaling ₹15.18 Cr.

Nagarani and Raju Raghavendra serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24230KA2015PTC081999

  • Company No.

    081999

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Aug 2015

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma

What products or services does Euploid Pharmaceuticals Private Limited offer?

Euploid Pharmaceuticals Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Cardiovascular Drugs & Medication, Diabetes Medicine.

Company report

Euploid Pharmaceuticals Private Limited

Explore comprehensive data for Euploid Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Euploid Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Nagarani Country flag representing In Director 04-Jun-2024Current
Raju Raghavendra Country flag representing In Director 04-Aug-2015Current

Financial Performance of Euploid Pharmaceuticals.

Euploid Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.58% increase. The company also saw a substantial fall in profitability, with a 283.91% decrease in profit. The company's net worth Soared by an impressive increase of 693.18%.

Euploid Pharmaceuticals revenue growth over time
Euploid Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
3.58%
Revenue from Operations
4.23%
Total Assets
197.68%
Profit or Loss
-283.91%
Net Worth
693.18%
EBITDA
17.91%

What is the Ownership and Shareholding Structure of Euploid Pharmaceuticals?

In 2023, Euploid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹15.18 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Canara Bank : 15.18 Cr

Latest Charge Details

DateLenderAmountStatus
16 Feb 2022Canara Bank₹15.18 CrOpen

How Many Employees Work at Euploid Pharmaceuticals?

Unlock and access historical data on people associated with Euploid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Euploid Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Euploid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euploid Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Euploid Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Euploid Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Nagarani was appointed as a Director was appointed as a Director on 04 Jun 2024 & has been associated with this company since 11 months 8 days .

  • Balance Sheet

    Euploid Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Charges

    A charge with Canara Bank of Rs. 15.18 Cr registered on 16 Feb 2022 with Charge ID 100570819 was modified on 28 Dec 2023.

  • Charges

    A charge with Canara Bank amounted to Rs. 15.18 Cr with Charge ID 100570819 was registered on 16 Feb 2022.

  • Director Appointment

    Raju Chowdappa Raghavendra was appointed as a Director was appointed as a Director on 04 Aug 2015 & has been associated with this company since 9 years 9 months .

Frequently asked questions

  • What is the Incorporation or founding date of Euploid Pharmaceuticals Private Limited?

    Euploid Pharmaceuticals Private Limited was incorporated on 04 Aug 2015.

  • What is authorized share capital and paid-up capital of Euploid Pharmaceuticals Private Limited?

    The authorized share capital of Euploid Pharmaceuticals Private Limited is ₹ 6.00 Cr and paid-up capital is ₹ 6.00 Cr.

  • Who are the current board members & directors of Euploid Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Euploid Pharmaceuticals Private Limited.

    • Nagarani
    • Raju Chowdappa Raghavendra

  • What is the registered address of Euploid Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Euploid Pharmaceuticals Private Limited is 29/2 No 15 Vinayaka Layout, K R Puram India, Bangalore, Karnataka, 560049.

  • What is the corporate identification number (CIN) and company number of Euploid Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Euploid Pharmaceuticals Private Limited is U24230KA2015PTC081999 and the company number is 081999 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Euploid Pharmaceuticals Private Limited?

    The Official website of Euploid Pharmaceuticals Private Limited is https://www.euploidpharmaceuticals.com

  • What has been the recent revenue trend for Euploid Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Euploid Pharmaceuticals Private Limited has risen by 3.58%.

  • What change has been observed in the net worth of Euploid Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Euploid Pharmaceuticals Private Limited has experienced an upsurge of 693.18%.

  • What are the total open charges for Euploid Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Euploid Pharmaceuticals Private Limited amount to ₹ 15.18 Cr.

  • When was the last Balance Sheet of Euploid Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Euploid Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development